Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Finasteride may help some women with hair loss, but better options exist.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

About one-third of dermatology patients in Ankara, Turkey use unconventional treatments for skin issues.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Tailor treatments for vitiligo to patient needs for best results.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Minoxidil treatment may cause hair loss.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Glycerin in hand cream can cause allergic skin reactions.